Stocks to Watch: Entrada, Blucora, Super Micro Computer – MarketWatch
By Patrick ChuEntrada Therapeutics Inc. received a clinical hold notice from the Food and Drug Administration regarding its investigational drug application for ENTR-601-44, a potential…